Coexisting central and obstructive sleep apnea is a challenging clinical situation. We report a case exhibiting an overnight shift from obstructive to central events. The central sleep apnea component was related to sleep instability, hyperventilation and low nocturnal PaCO 2 . Both types of respiratory events were successfully treated with adaptive servoventilation. 
Introduction
Coexisting central (CSA) and obstructive sleep apnea (OSA) is a growing concern [1, 2] as most of the patients referred for sleep studies suffer from comorbidities such as cardiovascular and/or neurologic disorders which increase the likelihood of both central and obstructive events [3] . Managing these complex sleep breathing disorders is challenging in terms of treatment strategy. Knowledge of the underlying pathophysiological mechanisms is crucial to understand why central and obstructive events coexist and to provide the most appropriate type of ventilatory support.
Case Report
A 59-year-old obese (BMI = 33.1) male subject treated for hypercholesterolemia and type II diabetes was referred to our sleep laboratory for snoring, nocturnal choking and gasping as well as poor sleep quality. The patient was a night shift worker complaining of morning headaches and daytime fatigue. Sleepiness (Epworth) and depression (Beck) scores were in the normal ranges (5/24 and 5/63, respectively). The patient's medications were aspirin and metformin. He had no history of smoking, alcohol consumption or illicit drug use. Physical examination revealed a normal cardiopulmonary and neurological status. His blood pressure was 139/87 mm Hg, and his heart rate was 69 beats/min. Polysomnography showed a severe sleep breathing 
Discussion
Excessive ventilation during sleep inducing low PaCO 2 brings patients close to their apnea threshold and induces central apneas and periodic breathing [2, 6, 7] . Our case illustrates that the overnight shift from OSA to CSA events was associated with a reduction in mean transcutaneous PtcCO 2 . A decrease in PtcCO 2 results from an increase in ventilation that can be explained by several factors.
First, the decrease in PtcCO 2 and shift in the apnea type may be linked to an overnight deterioration in cardiac function leading to hyperventilation. Our patient did not suffer from overt cardiac failure but had diastolic hypertension and diabetes, which are both frequently associated with diastolic cardiac failure, which is frequently underdiagnosed and associated with CSA.
Second, we cannot exclude an overnight fluid shift from the legs to the neck that can affect upper airway mechanics and lead to OSA, whereas fluid shift to the lungs can provoke hyperventilation, hypocapnia and CSA [8] .
Third, poor sleep quality and rapid transitions between wakefulness and sleep (i.e. the possibility of arous- al responses with hyperventilation) may be an additional factor. In patients with increased chemoresponsiveness, an increased central gain will promote and perpetuate respiratory instability and central events. This mechanism contributes to CSA in cardiac failure but is also a trigger for central apneas in any situation associated with chronic hyperventilation and/or sleep fragmentation [9] . Our case illustrates that central apneas occur concurrently with sleep instability and low PaCO 2 , both at sleep initiation and during the second part of the night. Figure 1 also depicts the central role of the sleeping position with illustrative evidence that the lateral sleeping position reduced the severity of CSA [10] . The respective contribution of unstable sleep, cardiac function and fluid shift is difficult to identify, but our clinical case clearly shows that hypocapnia, body position and quality of sleep are key mechanisms for CSA and OSA.
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